Scandion Oncology A/S: Financial statements 2019
CVR: 38613391
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Scandion Oncology A/S (CVR 38613391) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -11,160,744 and a net result of DKK -12,183,591 compared with DKK -8,182,558 the year before. Equity in the 2019 report amounted to DKK 18,338,281. The solvency ratio was 92.1%. The company had 3 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -11,160,744
- Profit/Loss
- DKK -12,183,591
- Equity
- DKK 18,338,281
- Total Assets
- DKK 19,902,610
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | -11.2M | -12.2M | 18.3M | 3 |
| 2018 | 0 | -7.4M | -8.2M | 12.6M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of October 1, 2019, Peter Høngård Andersen is registered as chairman of Scandion Oncology A/S.
As of October 1, 2019, Jørgen Vilhelm Løvenørn Bardenfleth is registered as vice chairman of Scandion Oncology A/S.
As of September 30, 2019, Peter Høngård Andersen has stepped down as vice chairman of Scandion Oncology A/S.
As of September 30, 2019, Jørgen Vilhelm Løvenørn Bardenfleth has stepped down as chairman of Scandion Oncology A/S.
As of May 29, 2019, Thomas Feldthus has joined the board of directors of Scandion Oncology A/S.
As of May 29, 2019, Peter Høngård Andersen is registered as vice chairman of Scandion Oncology A/S.
As of May 28, 2019, Thomas Feldthus has stepped down as vice chairman of Scandion Oncology A/S.
Scandion Oncology A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -8,182,558.
About Scandion Oncology A/S
Scandion Oncology A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 2017. The company has been dissolved on 6 October 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -6,100,000 and a net result of DKK -8,286,000. Equity in the 2025 report amounted to DKK 0.
